Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and advance cancer care worldwide. PLYMOUTH MEETING, Pa., ...

Crystal Denlinger, MD, FACP, incoming CEO of the National Comprehensive Cancer Network (NCCN), talks about the organization’s challenges and solutions to keeping up with the ever-changing oncology ...

The National Comprehensive Cancer Network ® (NCCN ®) - an alliance of leading cancer centers - and the NCCN Foundation ® proudly announce plans to make every book in the library of NCCN Guidelines for ...

Rural America regularly presents some of the greatest challenges to quality myeloma care and cancer care in general. Though ...

KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available ...

Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers “No other landscape in ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

Tislelizumab's inclusion in the National Comprehensive Cancer Network (NCCN) guidelines for hepatocellular carcinoma (HCC) as a category 1 recommendation marks an advancement in the treatment ...

The National Comprehensive Cancer Network joins a global day of advocacy to put people's individual needs and stories at the forefront of cancer care. World Cancer Day 2025 marks the start of the ...

On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care™, the National Comprehensive Cancer Network® (NCCN®) hosted its second roundtable, Value-Based ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...